Intellia Therapeutics (38I) Short Interest
DB • 38I • US45826J1051
As of Oct 21, 2026, ORTEX estimated 4.1% of free float sold short, 5,338.4 days to cover, cost to borrow 0.44%. Sign up for live short interest data.
DB • 38I • US45826J1051
As of Oct 21, 2026, ORTEX estimated 4.1% of free float sold short, 5,338.4 days to cover, cost to borrow 0.44%. Sign up for live short interest data.
This page tracks how heavily Intellia Therapeutics (DB:38I) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Intellia Therapeutics (DB: 38I) has a market capitalization of $1.72B. Last close €10.72 (as of 2026-11-05); 52-week range €6.75 to €15.92. ORTEX data as of 2026-10-21: short interest was 4.12% of free float, 5,338.4 days to cover and the average cost to borrow was 0.44%. Sign up for live short interest data.